Evaluation of Hemodynamics and Amount of Blood Flowing Through the Kidneys During Liver Transplant by Measuring Some Physiological Substances in Blood and Urines
This study is currently recruiting participants.
Verified July 2012 by Azienda Ospedaliera di Padova
Sponsor:
Azienda Ospedaliera di Padova
Information provided by (Responsible Party):
Dr. Paolo Feltracco, Azienda Ospedaliera di Padova
ClinicalTrials.gov Identifier:
NCT01650116
First received: July 24, 2012
Last updated: July 25, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to verify any existing relationship between urinary parameters (such as excretion of sodium, chlorine, urinary partial CO2 pressure [PuCO2]) and general volemic indicators (such as PiCCO, ScvO2, O2 delivery) during liver transplant.
| Condition |
|---|
|
Hypovolemia During Liver Transplantation Renal Hypoperfusion During Liver Transplantation |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Cross-Sectional |
| Official Title: | Evaluation of Sodium Urinary Excretion, Chlorine Urinary Excretion, Urinary Partial CO2 Pressure as Renal Perfusion Indicators During Liver Transplant. Comparison With Other Polemic State Indicators (Such as PiCCO, ScvO2, O2 Delivery). |
Resource links provided by NLM:
Further study details as provided by Azienda Ospedaliera di Padova:
Primary Outcome Measures:
- Determination of hemodynamic indicators (PiCCO, ScvO2, O2-delivery) and three urinary analytes (sodium, chloride, CO2 partial pressure) [ Time Frame: During the stay of the patient in the operating room (in average 8 hours) and the subsequent stay in the post-surgery intensive care unit (in average 5 days) ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 50 |
| Study Start Date: | July 2012 |
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Patients undergoing liver transplantation
Criteria
Inclusion Criteria:
- surgery for liver transplantation
- age 18-75
- ASA class I-III
Exclusion Criteria:
- age above 75 or under 18
- ASA class IV
- pre-existing renal failure
- pregnant patients
- patients unable to give written consent
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01650116
Contacts
| Contact: Paolo Feltracco, M.D. | +393493410225 | paolofeltracco@inwind.it |
| Contact: Stefania Barbieri, M.D. | +393479812611 | stefibarbieri@libero.it |
Locations
| Italy | |
| Azienda Ospedaliera di Padova | Recruiting |
| Padova, Italy, 35128 | |
| Contact +390498218285 | |
| Contact +390498218286 | |
| Principal Investigator: Carlo Ori, Prof. M.D. | |
| Principal Investigator: Paolo Feltracco, M.D. | |
| Sub-Investigator: Andrea Bortolato, M.D. | |
| Sub-Investigator: Stefania Barbieri, M.D. | |
| Sub-Investigator: Helmut Galligioni, M.D. | |
| Sub-Investigator: Daniele Bonvicini, M.D. | |
| Sub-Investigator: Tommaso Tonetti, student | |
Sponsors and Collaborators
Azienda Ospedaliera di Padova
Investigators
| Study Chair: | Carlo Ori, Prof. M.D. | Università degli Studi di Padova - Azienda Ospedaliera di Padova |
| Principal Investigator: | Paolo Feltracco, M.D. | Azienda Ospedaliera di Padova |
More Information
No publications provided
| Responsible Party: | Dr. Paolo Feltracco, Principal Investigator, Azienda Ospedaliera di Padova |
| ClinicalTrials.gov Identifier: | NCT01650116 History of Changes |
| Other Study ID Numbers: | 2661P |
| Study First Received: | July 24, 2012 |
| Last Updated: | July 25, 2012 |
| Health Authority: | Italy: Ethics Committee |
Keywords provided by Azienda Ospedaliera di Padova:
|
hypovolemia renal hypoperfusion liver transplantation sodium chloride |
PuCO2 ScvO2 PiCCO O2-delivery hemodynamic indexes |
Additional relevant MeSH terms:
|
Hypovolemia Pathologic Processes |
ClinicalTrials.gov processed this record on May 19, 2013